Your browser doesn't support javascript.
loading
Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Jumpei Ito; Rigel Suzuki; Keiya Uriu; Yukari Itakura; Jiri Zahradnik; Sayaka Deguchi; Lei Wang; Spyos Lytras; Tomokazu Tamura; Izumi Kida; Hesham Nasser; Maya Shofa; MST Monira Begum; Masumi Tsuda; Yoshikata Oda; Shigeru Fujita; Kumiko Yoshimatsu; Hayato Ito; Naganori Nao; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Yuki Yamamoto; Tetsuharu Nagamoto; Gideon Schreiber; - The Genotype to Phenotype Japan (G2P-Japan) Consortium; Akatsuki Saito; Keita Matsuno; Kazuo Takayama; Shinya Tanaka; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato.
Affiliation
  • Jumpei Ito; University of Tokyo
  • Rigel Suzuki; Hokkaido University
  • Keiya Uriu; University of Tokyo
  • Yukari Itakura; Hokkaido University
  • Jiri Zahradnik; Weizmann Institute of Science
  • Sayaka Deguchi; Kyoto University
  • Lei Wang; Hokkaido University
  • Spyos Lytras; University of Glasgow
  • Tomokazu Tamura; Hokkaido University
  • Izumi Kida; Hokkaido University
  • Hesham Nasser; Kumamoto University
  • Maya Shofa; University of Miyazaki
  • MST Monira Begum; Kumamoto University
  • Masumi Tsuda; Hokkaido University
  • Yoshikata Oda; Hokkaido University
  • Shigeru Fujita; University of Tokyo
  • Kumiko Yoshimatsu; Hokkaido University
  • Hayato Ito; Hokkaido University
  • Naganori Nao; Hokkaido University
  • Hiroyuki Asakura; Tokyo Metropolitan Institute of Public Health
  • Mami Nagashima; Tokyo Metropolitan Institute of Public Health
  • Kenji Sadamasu; Tokyo Metropolitan Institute of Public Health
  • Kazuhisa Yoshimura; Tokyo Metropolitan Institute of Public Health
  • Yuki Yamamoto; HiLung Inc.
  • Tetsuharu Nagamoto; HiLung Inc.
  • Gideon Schreiber; Weizmann Institute of Science
  • - The Genotype to Phenotype Japan (G2P-Japan) Consortium; -
  • Akatsuki Saito; University of Miyazaki
  • Keita Matsuno; Hokkaido University
  • Kazuo Takayama; Kyoto University
  • Shinya Tanaka; Hokkaido University
  • Takasuke Fukuhara; Hokkaido University
  • Terumasa Ikeda; Kumamoto University
  • Kei Sato; Institute of Medical Science, The University of Tokyo
Preprint in English | bioRxiv | ID: ppbiorxiv-519085
ABSTRACT
In late 2022, although the SARS-CoV-2 Omicron subvariants have highly diversified, some lineages have convergently acquired amino acid substitutions at five critical residues in the spike protein. Here, we illuminated the evolutionary rules underlying the convergent evolution of Omicron subvariants and the properties of one of the latest lineages of concern, BQ.1.1. Our phylogenetic and epidemic dynamics analyses suggest that Omicron subvariants independently increased their viral fitness by acquiring the convergent substitutions. Particularly, BQ.1.1, which harbors all five convergent substitutions, shows the highest fitness among the viruses investigated. Neutralization assays show that BQ.1.1 is more resistant to breakthrough BA.2/5 infection sera than BA.5. The BQ.1.1 spike exhibits enhanced binding affinity to human ACE2 receptor and greater fusogenicity than the BA.5 spike. However, the pathogenicity of BQ.1.1 in hamsters is comparable to or even lower than that of BA.5. Our multiscale investigations provide insights into the evolutionary trajectory of Omicron subvariants.
License
cc_by
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2022 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2022 Document type: Preprint
...